A randomized, open label study to investigate the impact of Bone Marker feedback (bio-feedback) on adherence to monthly Bonviva in women with post-menopausal osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 19 Jun 2006 New trial record.